化学疗法的

In addition to determining that humans use chemosignals to attract one another, the findings could one day be used to create new therapies to correct hormone imbalances—most notably alternatives to cortisol replacement, which is used in treat maladies such as Addison's disease (in which the adrenal glands fail to pump out enough cortisol, causing muscle weakness, weight loss and low blood pressure).

除了确定人类确实可以用化学信号彼此吸引，这一发现还将有助于荷尔蒙失衡新疗法的开发——值得一提的是，这类新疗法可能取代皮质醇替代疗法来治疗阿狄森症（阿狄森症：肾上腺不能分泌足够的皮质醇，从而引发肌肉乏力，体重减轻和低血压等症状）。

A Scottish biologist and pharmacologist Alexander Fleming published many articles on bacteriology, immunology, and chemotherapy.

苏格兰生物学家和药理学家亚利山大·弗莱明发表过多篇关于细菌学、免疫学和化学疗法的文章。

They say the likely treatment is radiation and kimono ferity chemotherapy .

他们说可能的治疗方式是射线疗法和化学疗法。

In this update from the GELA study, 399 patients age 60-80 years with untreated DLCL received eight cycles of standard CHOP every three weeks or eight cycles of R-CHOP (CHOP plus rituximab 375 mg/m2 the same day), and were followed for a median period of 18 months.

他们接受了8个疗程的常规CHOP化学疗法，每3周为一个疗程，或接受了8个疗程的Rituximab-CHOP联合疗法（CHOP疗法，加上同期进行的Rituximab治疗，Rituximab服用剂量为375 mg/m2），治疗后，追踪了大约18个月。

Phytotherapeutic and homeopathic products are used in preference to chemically synthesised allopathic products, provided that their therapeutic effect is effective.

如果植物疗法和顺势疗法的药品很有疗效，它们的使用优先于化学合成的对抗疗法的药品

Although Dr. Burstein agrees that metronomic chemotherapy alone "did not do all that much," he told Medscape that the combination with bevacizumab is encouraging and that a pilot study is being designed to look at the feasibility of combining bevacizumab with metronomic chemotherapy. The study will compare the combination treatment with bevacizumab alone, but it will not look at metronomic chemotherapy alone.28th Annual SABCS: Abstract 4. Presented Dec.

虽然Burstein医师同意仅接受节律性化学疗法几乎是没有帮助，但他向Medscape表示，结合bevacizumab的合并疗法是有潜力的，而且已经有初期试验检验结合bevacizumab与节律性化学疗法的可行性；这项试验将会比较合并试验与仅接受bevacizumab治疗的反应，但并不会检验仅接受节律性化学疗法的效果。

For Clark Haskins, MD, from New Mexico Oncology Hematology Consultants, Ltd, New Mexico Cancer Center, the data do not support the researchers' positive conclusions."The results were crummy," he told Medscape when asked what he thought of the strategy of using metronomic chemotherapy in advanced disease."The problem is that there are a lot of patients who don't want to take chemotherapy, so this strategy is trying to reach these patients," he said."Unfortunately, the data don't support that the strategy works."

新墨西哥癌症中心新墨西哥肿瘤血液肿瘤谘询家Clark Haskins医师表示，这项试验数据并不支持研究者的正面结论；当他被问到有关使用节律性化学疗法在进展性癌症病患的意见时，他向Medscape表示，这项试验结果并不显著，问题在於许多病患不想接受化学疗法，所以这项使用低剂量、持续使用的策略希望可以用在这些病患身上；但不幸的，这项试验的数据并不支持这样的做法是有效的。

For Clark Haskins, MD, from New Mexico Oncology Hematology Consultants, Ltd, New Mexico Cancer Center, the data do not support the researchers' positive conclusions."The results were crummy," he told Medscape when asked what he thought of the strategy of using metronomic chemotherapy in advanced disease."The problem is that there are a lot of patients who don't want to take chemotherapy, so this strategy is trying to reach these patients," he said."Unfortunately, the data don't support that the strategy works."

新墨西哥癌症中心新墨西哥肿瘤血液肿瘤咨询家Clark Haskins医师表示，这项试验数据并不支持研究者的正面结论；当他被问到有关使用节律性化学疗法在进展性癌症病患的意见时，他向Medscape表示，这项试验结果并不显著，问题在于许多病患不想接受化学疗法，所以这项使用低剂量、持续使用的策略希望可以用在这些病患身上；但不幸的，这项试验的数据并不支持这样的做法是有效的。

Despite the poor response rates in the chemotherapy-alone group, Dr. Burstein believes that metronomic chemotherapy combined with bevacizumab should be investigated further, given the tolerability of the agents and the preclinical rationale for efficacy. When asked why cyclophosphamide and methotrexate were selected for metronomic chemotherapy, he observed that many patients in this setting are already somewhat chemotherapy-resistant.

尽管只接受化学疗法的病患反应率很低，Burstein医师相信节律性化学疗法加上bevacizumab应该进一步研究，因为该药物的耐受性良好，而且临床前实验认为是有效的；当被问到为什么选择cyclophosphamide与methotrexate作为节律性化学疗法的药物，他观察发现，许多病患在这个时候已经对许多化学疗法产生抗药性。

Despite the poor response rates in the chemotherapy-alone group, Dr. Burstein believes that metronomic chemotherapy combined with bevacizumab should be investigated further, given the tolerability of the agents and the preclinical rationale for efficacy. When asked why cyclophosphamide and methotrexate were selected for metronomic chemotherapy, he observed that many patients in this setting are already somewhat chemotherapy-resistant.

尽管只接受化学疗法的病患反应率很低，Burstein医师相信节律性化学疗法加上bevacizumab应该进一步研究，因为该药物的耐受性良好，而且临床前实验认为是有效的；当被问到为什麼选择cyclophosphamide与methotrexate作为节律性化学疗法的药物，他观察发现，许多病患在这个时候已经对许多化学疗法产生抗药性。

According to the clear water experiment, aeration performance of the new equipment is good with high total oxygen transfer coefficient and oxygen utilization ratio.

曝气设备的动力效率在叶轮转速为120rpm～150rpm时取得最大值，此时氧利用率和充氧能力也具有较高值。

The environmental stability of that world - including its crushing pressures and icy darkness - means that some of its most famous inhabitants have survived for eons as evolutionary throwbacks, their bodies undergoing little change.

稳定的海底环境─包括能把人压扁的压力和冰冷的黑暗─意谓海底某些最知名的栖居生物已以演化返祖的样态活了万世，形体几无变化。